Gianluca Avallone

Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study

Paolo Dapavo, Niccolò Siliquini, Luca Mastorino et al. · Journal of Dermatological Treatment · 2021 · 56 citations

Medicine, Pharmacology, Pharmacotherapy +17

Risankizumab shows high efficacy and maintenance in improvement of response until week 52

Luca Mastorino, Sara Susca, Matteo Megna et al. · Dermatologic Therapy · 2022 · 46 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +10

Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study

Gianluca Avallone, Carlo Alberto Maronese, Giulia Murgia et al. · Journal of Clinical Medicine · 2023 · 33 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy

Luca Mastorino, Paolo Dapavo, Mattia Trunfio et al. · Acta Dermato Venereologica · 2022 · 32 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate‐to‐severe atopic dermatitis: A nationwide retrospective cohort study

Gianluca Avallone, Francesco Cavallo, Annalisa Tancredi et al. · Journal of the European Academy of Dermatology and Venereology · 2024 · 25 citations · Full text

Life Sciences, Dermatology, Immunology +16